Invest in the new world of personalised medicine

GeneS welcome serious and interested investors to back our mission to create a "Right Drug, RightDose, First Time" world that will transform personalised medicine. GeneS qualifies for the Early-Stage InnovationCompany (ESIC) incentive. 

Through ESIC, investors are eligible for:

If you are interested in investing in GeneS, please contact us at